Limited Partners

HarbourVest runs $1bn-plus clean-up secondaries sale on older pools

Fund of funds sales represented the majority of LP transactions by asset managers last year, according to a recent full-year 2023 volume report.

Secondaries is second-most popular strategy after private credit – Coller survey

Private equity secondaries will be a $500bn market by 2030, the firm’s founder and chief investment officer Jeremy Coller tells Secondaries Investor.

SI Decade: The birth of programmatic secondaries sales

In this sixth episode of the Decade of Secondaries Investing podcast miniseries, we sit down with HarbourVest Partners’ Jeffrey Keay and PJT Park Hill’s Adrian Millan to discuss the phenomenon of repeat sellers in the secondaries market.

Strategic Partners emerges as a buyer in Washington State portfolio sale

More LPs are considering secondaries sales as pricing has strengthened since last year, with high-quality buyout funds capturing pricing at the 90% or higher net asset value range.

What the SEC looks for in GP-led secondaries transactions

Iron Road Partners’ Igor Rozenblit – former co-head of the SEC’s private funds unit – details concerns and red flags the regulator will be looking for following the passing of its private market rules last year.

SI Decade: Inside the biggest regulation changes to secondaries

In episode five of the Decade of Secondaries Investing podcast miniseries, Iron Road Partners’ Igor Rozenblit and Ropes & Gray’s Isabel Dische discuss the regulatory landscape facing secondaries and analyse which rules are set to have the biggest impact.

What is driving LPs to the credit secondaries market?

LPs want liquidity and GPs want to be in a position to offer it to them, while both want secondaries volume.

StepStone leads on $762m Australian secondary deal

The innovative transaction involves StepStone providing funding for MLC Private Equity’s seed portfolio and additional capital for its new investments.

The next wave of programmatic secondaries sellers

Kaiser Permanente has returned to the secondaries market with its third billion-plus portfolio in three years. As first-timers come to market, the secondaries market is hopeful more LPs will take a regular approach in the years to come.

Kaiser Permanente shops ‘multi-billion dollar’ portfolio as pricing strengthens

The deal comes as LP secondaries sales keep steady and drive activity with strong pricing and sellers eager to capture liquidity from private equity portfolios.